ISRCTN27159806已完成未知
An open label study to assess the safety and efficacy of Atorvastatin/Amlodipine/Perindopril fixed-dose combination in adult patients, following four weeks of adequate treatment with atorvastatin, amlodipine and perindopril given concurrently
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Confirmed inadequate BP control before study drug dispensing: for combined systolic and diastolic hypertension
- •2. Confirmed LDL-C value by the laboratory test performed at Selection visit
- •3. Patients who provide written informed consent to participate in the study
- •4. Outpatients of 18 years of age or above (male and female)
排除标准
- •1. Known symptomatic orthostatic hypotension
- •2. Malignant hypertension
- •3. Secondary hypertension
- •4. Isolated diastolic hypertension
- •5. History of hypertension
- •6. Known diabetes mellitus type I or type II
- •7. History or current presence of lymphedema or leg edema (unilateral or bilateral) of venous origin
- •8. Presence of severe rhythm or conduction disorder
- •9. Any history of heart failure, New York Heart Association (NYHA) classification III or IV
- •10. Patients with contra-indications to statins, especially to Atorvastatin
- •11. Patients with contra-indications to calcium channel inhibitors, especially to Amlodipine
- •12. Patients with contra-indications to ACE inhibitors, especially to Perindopril arginine:
- •13. History of myopathy, familial history of hereditary muscular disorders
研究者
相似试验
Unknown
2 期
A Clinical Study to evaluate the Safety and Efficacy of LP011-09 in subjects with Allergic RhinitisCTRI/2012/03/002473aila Pharmaceutical Pvt Ltd40
已完成
4 期
An open label study to evaluate the safety and efficacy of Aclasta (Zoledronic acid) in treatment of patients with Glucocorticoid induced OsteoporosisCTRI/2010/091/000637ovartis Healthcare Pvt Limited60
进行中（未招募）
1 期
A study to evaluate the safety and effect of CFZ533 on patients with Graves’ diseaseGraves' diseaseMedDRA version: 19.0Level: LLTClassification code 10018706Term: Graves' diseaseSystem Organ Class: 100000004860EUCTR2015-005564-41-DEovartis Pharma Services AG15
进行中（未招募）
1 期
An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL)Children and adolescents aged 1-17 years at diagnosis, with Ph+ALLMedDRA version: 14.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaSystem Organ Class: 100000004864EUCTR2004-001647-30-ITA.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA550
进行中（未招募）
1 期
Open label study to assess the efficacy, safety and dosing of clevidipine in children undergoing surgery.EUCTR2013-001268-44-Outside-EU/EEAChiesi USA, Inc.80